Heskumdai:
Unfortunately, you do have a point.
AVH have a world class product, but it seems not a world class management capable of capitalising on the great work of Dr. Fiona Wood. That's been the problem since its Clinical Cell Culture days.
Ann: Appendix 4C quarterly and Company Update, page-3
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
0.000(0.00%) |
Mkt cap ! $168.2M | |||
| Open | High | Low | Value | Volume |
| $2.47 | $2.49 | $2.44 | $335.5K | 136.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4206 | $2.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.49 | 5666 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |